The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization

Journal of Allergy and Clinical Immunology - Tập 136 - Trang 1254-1264 - 2015
Shinji Noda1, Mayte Suárez-Fariñas1,2,3,4, Benjamin Ungar1,2, Soo Jung Kim2, Cristina de Guzman Strong5, Hui Xu2, Xiangyu Peng2, Yeriel D. Estrada2, Saeko Nakajima6, Tetsuya Honda6, Jung U. Shin7, Hemin Lee7, James G. Krueger1, Kwang-Hoon Lee7, Kenji Kabashima6, Emma Guttman-Yassky1,2,8
1Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY
2Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY
3Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY
4Department of Genetics and Genomics Science, Icahn Institute for Genomics and Multiscale Biology, New York, NY
5Division of Biology and Biomedical Sciences, Washington University, St Louis, Mo
6Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
7Department of Dermatology & Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea
8Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY

Tài liệu tham khảo

Leung, 2014, Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches, J Allergy Clin Immunol, 134, 769, 10.1016/j.jaci.2014.08.008 Hanifin, 2007, A population-based survey of eczema prevalence in the United States, Dermatitis, 18, 82, 10.2310/6620.2007.06034 Eichenfield, 2014, Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis, J Am Acad Dermatol, 70, 338, 10.1016/j.jaad.2013.10.010 Silverberg, 2013, Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study, J Allergy Clin Immunol, 132, 1132, 10.1016/j.jaci.2013.08.031 Margolis, 2014, Persistence of mild to moderate atopic dermatitis, JAMA Dermatol, 150, 593, 10.1001/jamadermatol.2013.10271 Flohr, 2014, New insights into the epidemiology of childhood atopic dermatitis, Allergy, 69, 3, 10.1111/all.12270 Tokura, 2010, Extrinsic and intrinsic types of atopic dermatitis, J Dermatol Sci, 58, 1, 10.1016/j.jdermsci.2010.02.008 Noda, 2015, The translational revolution and use of biologics in patients with inflammatory skin diseases, J Allergy Clin Immunol, 135, 324, 10.1016/j.jaci.2014.11.015 Gittler, 2012, Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis, J Allergy Clin Immunol, 130, 1344, 10.1016/j.jaci.2012.07.012 Suárez-Fariñas, 2013, Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis, J Allergy Clin Immunol, 132, 361, 10.1016/j.jaci.2013.04.046 Guttman-Yassky, 2008, Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis, J Immunol, 181, 7420, 10.4049/jimmunol.181.10.7420 Guttman-Yassky, 2009, Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis, J Allergy Clin Immunol, 124, 1235, 10.1016/j.jaci.2009.09.031 Leonardi, 2012, Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis, N Engl J Med, 366, 1190, 10.1056/NEJMoa1109997 Papp, 2012, Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis, N Engl J Med, 366, 1181, 10.1056/NEJMoa1109017 Sofen, 2014, Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis, J Allergy Clin Immunol, 133, 1032, 10.1016/j.jaci.2014.01.025 Langley, 2014, Secukinumab in plaque psoriasis—results of two phase 3 trials, N Engl J Med, 371, 326, 10.1056/NEJMoa1314258 Beck, 2014, Dupilumab treatment in adults with moderate-to-severe atopic dermatitis, N Engl J Med, 371, 130, 10.1056/NEJMoa1314768 Hamilton, 2014, Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis, J Allergy Clin Immunol, 134, 1293, 10.1016/j.jaci.2014.10.013 Torrelo, 2014, Atopic dermatitis in different skin types. What is to know?, J Eur Acad Dermatol Venereol, 28, 2, 10.1111/jdv.12480 Saeki, 2006, Prevalence of atopic dermatitis determined by clinical examination in Japanese adults, J Dermatol, 33, 817, 10.1111/j.1346-8138.2006.00187.x Sugiura, 1998, Prevalence of childhood and adolescent atopic dermatitis in a Japanese population: comparison with the disease frequency examined 20 years ago, Acta Derm Venereol, 78, 293, 10.1080/000155598441891 Koga, 2008, Possible pathogenic role of Th17 cells for atopic dermatitis, J Invest Dermatol, 128, 2625, 10.1038/jid.2008.111 Czarnowicki, 2015, Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population, J Allergy Clin Immunol, 136, 104, 10.1016/j.jaci.2015.01.020 Tintle, 2011, Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response, J Allergy Clin Immunol, 128, 583, 10.1016/j.jaci.2011.05.042 Khattri, 2014, Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology, J Allergy Clin Immunol, 133, 1626, 10.1016/j.jaci.2014.03.003 Johnson-Huang, 2010, Effective narrow-band UVB radiation therapy suppresses the IL-23/IL-17 axis in normalized psoriasis plaques, J Invest Dermatol, 130, 2654, 10.1038/jid.2010.166 Jolliffe, 1986 Stacklies, 2007, pcaMethods—a bioconductor package providing PCA methods for incomplete data, Bioinformatics, 23, 1164, 10.1093/bioinformatics/btm069 Scholz, 2005, Non-linear PCA: a missing data approach, Bioinformatics, 21, 3887, 10.1093/bioinformatics/bti634 Papp, 2012, Anti-IL-17 receptor antibody AMG 827 leads to rapid clinical response in subjects with moderate to severe psoriasis: results from a phase I, randomized, placebo-controlled trial, J Invest Dermatol, 132, 2466, 10.1038/jid.2012.163 Guttman-Yassky, 2007, Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis, J Allergy Clin Immunol, 119, 1210, 10.1016/j.jaci.2007.03.006 Kim, 2008, Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6, Clin Immunol, 126, 332, 10.1016/j.clim.2007.11.006 Esaki, 2015, Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection, J Allergy Clin Immunol, 135, 153, 10.1016/j.jaci.2014.10.037 Suárez-Fariñas, 2015, RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications, J Allergy Clin Immunol, 135, 1218, 10.1016/j.jaci.2015.03.003 Bhattacharya, 2014, Efficacy of systemic treatments for atopic dermatitis in racial and ethnic minorities in the United States, JAMA Dermatol, 150, 1232, 10.1001/jamadermatol.2014.1674 Bin, 2014, Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum, J Allergy Clin Immunol, 134, 848, 10.1016/j.jaci.2014.07.018 Heratizadeh, 2011, Food allergy and atopic dermatitis: how are they connected?, Curr Allergy Asthma Rep, 11, 284, 10.1007/s11882-011-0202-y McLean, 2008, Filaggrin variants confer susceptibility to asthma, J Allergy Clin Immunol, 121, 1294, 10.1016/j.jaci.2008.02.039 Brown, 2012, One remarkable molecule: filaggrin, J Invest Dermatol, 132, 751, 10.1038/jid.2011.393 Irvine, 2011, Filaggrin mutations associated with skin and allergic diseases, N Engl J Med, 365, 1315, 10.1056/NEJMra1011040 Czarnowicki, 2015, Early pediatric atopic dermatitis shows only a CLA+ Th2/Th1 imbalance, while adults acquire CLA+ Th22/Tc22 subsets, J Allergy Clin Immunol, 10.1016/j.jaci.2015.05.049 Moore, 2004, Perinatal predictors of atopic dermatitis occurring in the first six months of life, Pediatrics, 113, 468, 10.1542/peds.113.3.468 Suárez-Fariñas, 2011, Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities, J Allergy Clin Immunol, 127, 954, 10.1016/j.jaci.2010.12.1124 Alsaad, 2005, My approach to superficial inflammatory dermatoses, J Clin Pathol, 58, 1233, 10.1136/jcp.2005.027151 Yoshida, 2014, Distinct behavior of human Langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis, J Allergy Clin Immunol, 134, 856, 10.1016/j.jaci.2014.08.001 Guttman-Yassky, 2011, Contrasting pathogenesis of atopic dermatitis and psoriasis—part II: immune cell subsets and therapeutic concepts, J Allergy Clin Immunol, 127, 1420, 10.1016/j.jaci.2011.01.054 Hao, 2014, Targeting interleukin-22 in psoriasis, Inflammation, 37, 94, 10.1007/s10753-013-9715-y Sabat, 2014, Therapeutic opportunities of the IL-22-IL-22R1 system, Nat Rev Drug Discov, 13, 21, 10.1038/nrd4176 Sa, 2007, The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis, J Immunol, 178, 2229, 10.4049/jimmunol.178.4.2229 Witte, 2014, IL-19 is a component of the pathogenetic IL-23/IL-17 cascade in psoriasis, J Invest Dermatol, 134, 2757, 10.1038/jid.2014.308 Huang, 2008, Potentiation of IL-19 expression in airway epithelia by IL-17A and IL-4/IL-13: important implications in asthma, J Allergy Clin Immunol, 121, 1415, 10.1016/j.jaci.2008.04.016 Danso, 2014, TNF-α and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents, J Invest Dermatol, 134, 1941, 10.1038/jid.2014.83 Mills, 2008, Induction, function and regulation of IL-17-producing T cells, Eur J Immunol, 38, 2636, 10.1002/eji.200838535 Paust, 2012, Chemokines play a critical role in the cross-regulation of Th1 and Th17 immune responses in murine crescentic glomerulonephritis, Kidney Int, 82, 72, 10.1038/ki.2012.101 Damsker, 2010, Th1 and Th17 cells: adversaries and collaborators, Ann N Y Acad Sci, 1183, 211, 10.1111/j.1749-6632.2009.05133.x Noster, 2014, IL-17 and GM-CSF expression are antagonistically regulated by human T helper cells, Sci Transl Med, 6, 241ra80, 10.1126/scitranslmed.3008706 Zhang, 2008, Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease, J Allergy Clin Immunol, 122, 961, 10.1016/j.jaci.2008.07.008 Jiang, 2011, The characterization of IL-17A expression in patients with chronic rhinosinusitis with nasal polyps, Am J Rhinol Allergy, 25, e171, 10.2500/ajra.2011.25.3645 Bachert, 2012, Chronic rhinosinusitis and asthma: novel understanding of the role of IgE ‘above atopy’, J Intern Med, 272, 133, 10.1111/j.1365-2796.2012.02559.x Malajian, 2015, New pathogenic and therapeutic paradigms in atopic dermatitis, Cytokine, 73, 311, 10.1016/j.cyto.2014.11.023 Dunbar, 2011, A randomized double-blind study comparing 25 and 50 mg TC-1734 (AZD3480) with placebo, in older subjects with age-associated memory impairment, J Psychopharmacol, 25, 1020, 10.1177/0269881110367727 Lee, 2011, Age-associated alteration in naive and memory Th17 cell response in humans, Clin Immunol, 140, 84, 10.1016/j.clim.2011.03.018 Samorano, 2014, Inadequate response to ustekinumab in atopic dermatitis—a report of two patients, J Eur Acad Dermatol Venereol Fernández-Antón Martínez, 2014, Ustekinumab in the treatment of severe atopic dermatitis: a preliminary report of our experience with 4 patients, Actas Dermosifiliogr, 105, 312, 10.1016/j.ad.2013.05.003 Agusti-Mejias, 2013, Severe refractory atopic dermatitis in an adolescent patient successfully treated with ustekinumab, Ann Dermatol, 25, 368, 10.5021/ad.2013.25.3.368 Puya, 2012, Treatment of severe refractory adult atopic dermatitis with ustekinumab, Int J Dermatol, 51, 115, 10.1111/j.1365-4632.2011.05195.x Nast, 2015, Efficacy and safety of systemic long-term treatments for moderate-to-severe psoriasis—a systematic review and meta-analysis, J Invest Dermatol, 10.1038/jid.2015.206 Gordon, 2014, A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasis, J Am Acad Dermatol, 71, 1176, 10.1016/j.jaad.2014.07.048 Eyerich, 2011, Mutual antagonism of T cells causing psoriasis and atopic eczema, N Engl J Med, 365, 231, 10.1056/NEJMoa1104200 Quaranta, 2014, Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema, Sci Transl Med, 6, 244ra90, 10.1126/scitranslmed.3008946 Nestle, 2009, Psoriasis, N Engl J Med, 361, 496, 10.1056/NEJMra0804595 Bieber, 2008, Atopic dermatitis, N Engl J Med, 358, 1483, 10.1056/NEJMra074081 Kubota, 2015, Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database, BMJ Open, 5, e006450, 10.1136/bmjopen-2014-006450 Kim, 2015, Genome-wide association study of recalcitrant atopic dermatitis in Korean children, J Allergy Clin Immunol, 10.1016/j.jaci.2015.03.030 Esparza-Gordillo, 2009, A common variant on chromosome 11q13 is associated with atopic dermatitis, Nat Genet, 41, 596, 10.1038/ng.347 Sun, 2011, Genome-wide association study identifies two new susceptibility loci for atopic dermatitis in the Chinese Han population, Nat Genet, 43, 690, 10.1038/ng.851 Ahn, 2014, The role of air pollutants in atopic dermatitis, J Allergy Clin Immunol, 134, 993, 10.1016/j.jaci.2014.09.023 Sargen, 2014, Warm, humid, and high sun exposure climates are associated with poorly controlled eczema: PEER (Pediatric Eczema Elective Registry) cohort, 2004-2012, J Invest Dermatol, 134, 51, 10.1038/jid.2013.274 2012, Structure, function and diversity of the healthy human microbiome, Nature, 486, 207, 10.1038/nature11234 Grice, 2011, The skin microbiome, Nat Rev Microbiol, 9, 244, 10.1038/nrmicro2537